Acadia Pharmaceuticals to Present at Upcoming Investor Conferences
May 03 2022 - 4:05PM
Business Wire
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that
it will participate at the following upcoming investor
conferences:
BofA Securities 2022 Healthcare Conference Fireside Chat:
Tuesday, May 10, 2022 at 3:20 p.m. Pacific Time in Las Vegas,
NV
2022 RBC Capital Markets Global Healthcare Conference
Fireside Chat: Wednesday, May 18, 2022 at 4:05 p.m. Eastern Time in
New York, NY
Live webcasts of the presentations will be accessible on the
company’s website, www.acadia-pharm.com, under the investors
section and an archived recording will be available on the website
for approximately one month following each presentation.
About Acadia Pharmaceuticals
Acadia is advancing breakthroughs in neuroscience to elevate
life. For more than 25 years we have been working at the forefront
of healthcare to bring vital solutions to people who need them
most. We developed and commercialized the first and only approved
therapy for hallucinations and delusions associated with
Parkinson’s disease psychosis. Our late-stage development efforts
are focused on treating psychosis in patients with dementia, the
negative symptoms of schizophrenia and Rett syndrome. Our
early-stage development efforts are focused on novel approaches to
pain management, cognition and neuropsychiatric symptoms in central
nervous system disorders. For more information, visit us at
www.acadia-pharm.com and follow us on LinkedIn and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220503006067/en/
Media Contact: Acadia Pharmaceuticals Inc. Deb Kazenelson (818)
395-3043 media@acadia-pharm.com
Investor Contact: Acadia Pharmaceuticals Inc. Mark Johnson, CFA
(858) 261-2771 ir@acadia-pharm.com
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Sep 2023 to Sep 2024